期刊文献+

疣孢菌FIM090395细胞毒活性次级代谢产物的研究

Secondary metabolites with cytotoxic activities produced by Verrucosispora sp. FIM090395
下载PDF
导出
摘要 目的研究分离自海洋沉积物的疣孢菌FIM090395产生的次级代谢产物。方法采用HP-20大孔吸附树脂、正相硅胶、Sephadex LH-20葡聚糖凝胶和反相C18柱层析等方法,对菌株FIM090395次级代谢产物进行分离纯化。通过紫外光谱、质谱、核磁共振等波谱学方法对化合物进行结构鉴定。结果与结论分离得到化合物1和化合物2,结构解析确定它们分别与proximicin A和B同质,活性研究表明化合物1对肿瘤细胞株MDA-MB-231(乳腺癌细胞)、SW620(结肠癌细胞)、SMMC7721(肝癌细胞)和CNE-2(鼻咽癌细胞)具有一定的抑制作用,其IC50值分别为23.49、13.48、34.96和16.28μg/mL;化合物2对肿瘤细胞株K562(白血病细胞)具有一定的抑制作用,其IC50值为25.69μg/mL,对MDA-MB-231和CNE-2的抑制增殖作用较弱。 Objective To study the metabolites of Verrucosispora FIM090395 from marine sediments. Methods The metabolites from the culture filtrate of FIM090395 were purified by macroporous resin HP-20, silica gel, sephadex LH-20 and C18 reversed phase column chromatography. The structure of the compounds were determined by UV spectra, LC-MS,^ 1H and ^13C-NMR data analyses. Results and Conclusion Two compounds(1 and 2) were isolated from the culture filtrate, they were identified as proximicin A and B, respectively. Compound 1 showed in vitro growth inhibitory activity against the tumor cell lines MDA-MB-231, SW620, SMMC7721 and CNE-2 with ICso values of 23.49, 13.48, 34.96 and 16.28μg/mL, respectively.Therefore Compound 2 showed growth inhibitory activity against K562 cells with IC50 values of 25.69μg/mL, almost no activity against MDA-MB-231 and CNE-2 cells.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2014年第2期102-105,共4页 Chinese Journal of Antibiotics
基金 福建省重点项目(2012Y0077 2011R1010-2) 福建省自然科学基金(2011J01094 2012J01093) 国家科技重大专项(2010ZX09401-403 2012ZX09301002-003)
关键词 疣孢菌 肿瘤细胞毒活性 次级代谢产物 Proximicins Verrucosispora Cytotoxic activities Secondary metabolites Proximicins
  • 相关文献

参考文献14

  • 1Fenical W,Jensen P R. Developing a new resource for drug discovery:marine aetinomyeete bacteria[J].Nat cheml Biol,2006,(12):666-673.
  • 2Goodfellow M,Fiedler H P. A guide to successful bioprospecting:informed by actinobacterial systematics[J].{H}Antonie Van Leeuwenboek,2010,(2):119-142.
  • 3Rateb M E,Houssen W E,Harrison W T. Diverse metabolic profiles of a Streptomyces Strain isolated from a hyper-arid environment[J].{H}Journal of Natural Products,2011,(9):1965-1971.
  • 4Rateb M E,Houssen W E,Arnold M. Chaxamycins A-D,Bioactive Ansamycins from a Hyper-arid Desert Streptomyces sp[J].{H}Journal of Natural Products,2011,(6):1491-1499.
  • 5Feling R H,Buchanan G O,Mincer T J. Salinosporamide A:a highly cytotoxic proteasome inhibitor from a novel microbial source,a marine bacterium of the new genus Salinospora[J].{H}Angew Chem Int Ed Engl,2003,(3):355-357.
  • 6Williams P G,Buchanan G O,Feling R H. New cytotoxic salinosporamides from the marine Actinomycete Salinispora tropica[J].{H}Journal of Organic Chemistry,2005,(16):6196-6203.
  • 7Butler M S. Natural products to drugs:natural productderived compounds in clinical trials[J].{H}Natural Product Reports,2008,(3):475-516.
  • 8Riedlinger J,Reicko A,Zaehner H. Abyssomicins,inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032[J].{H}Journal of Antibiotics(Tokyo),2004,(4):271-279.
  • 9Fiedler H P,Bruntner C,Riedlinger J. Proximicin A,B and C,novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora[J].JAntibiot(Tokyo),2008,(3):158-163.
  • 10Schneider K,Keller S,Wolter F E. Proximicins A,B,and C-antitumor furan analogues of netropsin from the marine actinomycete Verrucosispora-induce upregulation of p53 and the cyclin kinase inhibitor p21 in AGS cells[J].{H}Angew Chem Int Ed Engl,2008,(17):3258-3261.

二级参考文献12

  • 1ZangX(臧旭) HuangM(黄敏).Advances in studies of antitumor metabolites from marine microorganisms[J].中国微生态学杂志,22:949-953.
  • 2LiuYL(刘燕兰) XiaoLH(肖丽华) WuM(吴敏) etal.Advances in studies of antitumor metabolites from marine microorganisms[J].中医药导报,13:114-116.
  • 3FuJZ(傅俊曾) JiLX(冀兰鑫) XieCF(谢春锋).Biologically active natural products from Streptomyces microorganisms[J].药物评价研究,33:153-158.
  • 4LiuL(刘丽) HuJC(胡江春) WangSJ(王书锦).Progress in studies on bioactive metabolites of sponge associated microbes[J].天然产物研究与开发,16:477-481.
  • 5Prudhomme J,McDaniel E,Ponts N,et al.Marine actinomycetes:a new surce of compounds against the human malaria parasite.PLoS ONE,2008,3:2335-2338.
  • 6Fiedler HP,Bruntner C,Riedlinger J,et al.Proximicin A,B and C,novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora.J Antibiot (Tokyo),2008,61:158-163.
  • 7Riedlinger J,Reicke A,Zahner H,et al.Abyssomicins,inhibitors of the para-aminobenzoic acid pathway producedby the marine Verrucosispora strain AB-18-032.J Antibiot (Tokyo),2004,57:271-279.
  • 8Shirai M,Okuda M,Motohashi K,et al.Terpenoids produced by actinomycetes:isolation,structural elucidation and biosynthesis of new diterpenes,gifhornenolones A and B from Verrucosispora gifhornensis YM28-088.J Antibiot (Tokyo),2010,63:245-250.
  • 9Furukawa S.In vitro chemosensitivity of hepatocellular carcinoma for hepatic arterial infusion chemotherapy using the MTT assay with the combinations of antitumor drugs.Kurume Med J,2004,51:25-33.
  • 10Xu FM,Morikawa T,Matsuda H,et al.Structures of new sesquiterpenes and hepatoprotective constituents from the egyptian herbal medicine cyperus longus.J Nat prod,2004,67:569-576.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部